Kraehenbuehl, L.; Winkelbeiner, N.; Turko, P.; Staeger, R.; Ghosh, A.; Kaiser, V.; Stadler, P.-C.; Nordmann, T.M.; Brüggen, M.-C.; Levesque, M.P.;
et al. Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted. Cancers 2025, 17, 1992.
https://doi.org/10.3390/cancers17121992
AMA Style
Kraehenbuehl L, Winkelbeiner N, Turko P, Staeger R, Ghosh A, Kaiser V, Stadler P-C, Nordmann TM, Brüggen M-C, Levesque MP,
et al. Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted. Cancers. 2025; 17(12):1992.
https://doi.org/10.3390/cancers17121992
Chicago/Turabian Style
Kraehenbuehl, Lukas, Nicola Winkelbeiner, Patrick Turko, Ramon Staeger, Adhideb Ghosh, Vivienn Kaiser, Pia-Charlotte Stadler, Thierry M. Nordmann, Marie-Charlotte Brüggen, Mitchell P. Levesque,
and et al. 2025. "Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted" Cancers 17, no. 12: 1992.
https://doi.org/10.3390/cancers17121992
APA Style
Kraehenbuehl, L., Winkelbeiner, N., Turko, P., Staeger, R., Ghosh, A., Kaiser, V., Stadler, P.-C., Nordmann, T. M., Brüggen, M.-C., Levesque, M. P., Contassot, E., French, L. E., Dummer, R., & Meier-Schiesser, B.
(2025). Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted. Cancers, 17(12), 1992.
https://doi.org/10.3390/cancers17121992